Treatment of Anxiety from Being Left Alone in Older Adults
Cognitive Behavioral Therapy (CBT) delivered individually is the first-line treatment for anxiety in older adults, including anxiety from being left alone, with SSRIs (specifically sertraline or escitalopram) as the preferred pharmacologic option when psychotherapy is unavailable or insufficient. 1
Initial Assessment and Non-Pharmacological Approaches
Before initiating any treatment, rule out underlying medical causes of anxiety symptoms, assess for medication side effects contributing to anxiety, and address sensory impairments that may exacerbate symptoms. 2 Explore the patient's specific concerns about being alone, ensure effective communication and orientation, and treat any reversible causes of anxiety. 1
Cognitive Behavioral Therapy (First-Line)
CBT is the psychotherapy with the highest level of evidence for anxiety disorders in older adults and should be prioritized when available. 1, 2
- Individual face-to-face CBT is superior to group therapy in terms of clinical and health-related economic effectiveness. 3
- CBT can be delivered in the patient's own home, which is particularly relevant for older adults with anxiety about being left alone. 4
- Remote CBT (via telehealth) is highly effective for older adults, with a significant effect size of -0.63 for reducing anxiety symptoms compared to non-CBT controls. 5
- If the patient does not want face-to-face CBT, self-help with professional support based on CBT is a viable alternative. 3, 1
Treatment duration and monitoring:
- CBT typically requires 12-20 sessions for meaningful improvement, though briefer interventions (6 or fewer sessions of 15-30 minutes) adapted for primary care settings can be effective. 6
- Assess treatment response at 4 and 8 weeks using standardized validated instruments. 1
- Treatment gains are maintained at follow-up in 77.8% of effective interventions. 3, 6
Additional Non-Pharmacological Interventions
For older adults who cannot access CBT or as adjunctive treatments:
- Motivational interviewing combined with psychoeducation and breathing techniques has demonstrated significant anxiety reduction at 3-month follow-up in patients aged 60 and older. 2
- Music therapy, massage, mindfulness, yoga, and pleasant activities have shown potential for alleviating anxiety in older adults. 7, 8
Pharmacological Treatment
When psychotherapy is unavailable, declined by the patient, or insufficient after 8 weeks despite good adherence, initiate pharmacotherapy. 1
Preferred First-Line Medications
Sertraline and escitalopram are the preferred SSRIs for older adults due to favorable safety profiles and low potential for drug interactions. 1
Dosing strategy for older adults:
- Start low and go slow: Begin sertraline at 25 mg daily (half the standard adult starting dose). 1
- Escitalopram has the least effect on CYP450 isoenzymes, resulting in lower propensity for drug interactions—critical in elderly patients often taking multiple medications. 1
- Increase doses at 1-2 week intervals for sertraline, monitoring for tolerability. 1
Alternative first-line option:
- SNRIs (venlafaxine or duloxetine) are appropriate alternatives if SSRIs are ineffective or not tolerated. 1
Medications to Avoid
Paroxetine and fluoxetine should generally be avoided in older adults. 1
- Paroxetine has significant anticholinergic properties and increased risk of suicidal thinking. 1
- Fluoxetine has a very long half-life and extensive CYP2D6 interactions, making it problematic in elderly patients. 1
Benzodiazepines (e.g., lorazepam) require extreme caution:
- If necessary, reduce lorazepam dose to 0.25-0.5 mg in elderly patients, with a maximum of 2 mg in 24 hours. 1
- Use lower doses with shorter half-lives. 1
Monitoring and Treatment Duration
- Initial adverse effects of SSRIs can include anxiety or agitation, which typically resolve within 1-2 weeks. 1
- Review all current medications for potential interactions, particularly with CYP450 substrates. 1
- Monitor for QT prolongation if using citalopram (avoid doses >20 mg daily in patients >60 years old). 1
- For a first episode of anxiety, continue treatment for at least 4-12 months after symptom remission. 1
- For recurrent anxiety, longer-term or indefinite treatment may be beneficial. 1
Treatment Adjustment
If symptoms are stable or worsening after 8 weeks despite good adherence:
- Switch to a different SSRI or SNRI. 1
- Add a psychological intervention to pharmacotherapy. 1
- Consider combination therapy (CBT plus medication) for severe cases. 6
Common Pitfalls to Avoid
- Do not discontinue SSRIs abruptly—taper gradually to avoid discontinuation syndrome (dizziness, paresthesias, anxiety, irritability). 1
- Failing to identify and treat underlying medical causes of anxiety before initiating treatment. 2
- Using high doses of medications without appropriate dose adjustments for elderly patients. 2
- Relying solely on medication without addressing underlying cognitive and behavioral patterns related to being alone. 6
- Neglecting to assess treatment response systematically using standardized anxiety rating scales. 1, 6